Similar articles for PMID: 26973271

Year	Number of Results
1986	1
2002	2
2003	1
2004	3
2005	7
2006	3
2007	6
2008	7
2009	7
2010	11
2011	11
2012	12
2013	13
2014	17
2015	22
2016	33
2017	43
2018	35
2019	16
2020	10
2021	13
2022	9
2023	3
2024	0

1

Combination of Urinary Sodium/Creatinine Ratio and Plasma Brain Natriuretic Peptide Level Predicts Successful Tolvaptan Therapy in Patients With Heart Failure and Volume Overload.

Sato Y, Dohi K, Watanabe K, Tanimura M, Takeuchi T, Sugiura E, Sugimoto T, Kumagai N, Ogura T, Nakamori S, Fujimoto N, Yamada N, Ito M. Sato Y, et al. Int Heart J. 2016;57(2):211-9. doi: 10.1536/ihj.15-330. Epub 2016 Mar 11. Int Heart J. 2016. PMID: 26973271 Free article.

2

Short-term effects of low-dose tolvaptan on hemodynamic parameters in patients with chronic heart failure.

Watanabe K, Dohi K, Sugimoto T, Yamada T, Sato Y, Ichikawa K, Sugiura E, Kumagai N, Nakamori S, Nakajima H, Hoshino K, Machida H, Okamoto S, Onishi K, Nakamura M, Nobori T, Ito M. Watanabe K, et al. J Cardiol. 2012 Dec;60(6):462-9. doi: 10.1016/j.jjcc.2012.09.002. Epub 2012 Oct 12. J Cardiol. 2012. PMID: 23068288 Free article.

3

Urine sodium excretion after tolvaptan administration is dependent upon baseline serum sodium levels: a possible explanation for the improvement of hyponatremia with scarce chance of hypernatremia by a vasopressin receptor antagonist.

Imamura T, Kinugawa K, Minatsuki S, Muraoka H, Kato N, Inaba T, Maki H, Hatano M, Yao A, Komuro I. Imamura T, et al. Int Heart J. 2014;55(2):131-7. doi: 10.1536/ihj.13-221. Epub 2014 Mar 14. Int Heart J. 2014. PMID: 24632953 Free article.

4

Effect of tolvaptan on acute heart failure with hyponatremia--a randomized, double blind, controlled clinical trial.

Shanmugam E, Doss CR, George M, Jena A, Rajaram M, Ramaraj B, Anjaneyan K, Kanagesh B. Shanmugam E, et al. Indian Heart J. 2016 Apr;68 Suppl 1(Suppl 1):S15-21. doi: 10.1016/j.ihj.2015.07.006. Epub 2015 Nov 12. Indian Heart J. 2016. PMID: 27056648 Free PMC article. Clinical Trial.

5

Mechanisms of Diuresis for Acute Decompensated Heart Failure by Tolvaptan.

Nomoto H, Satoh Y, Kamiyama M, Yabe K, Masumura M, Sakakibara A, Yamashita S, Suzuki M, Sugiyama T, Oumi T, Ohno M, Takahashi Y, Isobe M. Nomoto H, et al. Int Heart J. 2017 Aug 3;58(4):593-600. doi: 10.1536/ihj.16-438. Epub 2017 Jul 13. Int Heart J. 2017. PMID: 28701677 Free article. Clinical Trial.

6

Use of tolvaptan in patients hospitalized for worsening chronic heart failure with severe hyponatremia: The initial experience at a single-center in Turkey.

Sağ S, Aydın Kaderli A, Yıldız A, Gül BC, Özdemir B, Baran İ, Güllülü S, Aydınlar A, Çavuşoğlu Y. Sağ S, et al. Turk Kardiyol Dern Ars. 2017 Jul;45(5):415-425. doi: 10.5543/tkda.2017.80026. Turk Kardiyol Dern Ars. 2017. PMID: 28694395 Free article.

7

Chronic administration of oral vasopressin type 2 receptor antagonist tolvaptan exerts both myocardial and renal protective effects in rats with hypertensive heart failure.

Morooka H, Iwanaga Y, Tamaki Y, Takase T, Akahoshi Y, Nakano Y, Fujiki H, Miyazaki S. Morooka H, et al. Circ Heart Fail. 2012 Jul 1;5(4):484-92. doi: 10.1161/CIRCHEARTFAILURE.111.965392. Epub 2012 May 24. Circ Heart Fail. 2012. PMID: 22628529

8

Effects of Tolvaptan With or Without the Pre-Administration of Renin-Angiotensin System Blockers in Hospitalized Patients With Acute Decompensated Heart Failure.

Adachi S, Miura SI, Shiga Y, Arimura T, Morii J, Kuwano T, Kitajima K, Iwata A, Morito N, Fujimi K, Yahiro E, Nishikawa H, Saku K. Adachi S, et al. Int Heart J. 2017 May 31;58(3):385-392. doi: 10.1536/ihj.16-220. Epub 2017 May 8. Int Heart J. 2017. PMID: 28484118 Free article.

9

Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure.

Katsumata M, Hirawa N, Sumida K, Kagimoto M, Ehara Y, Okuyama Y, Fujita M, Fujiwara A, Kobayashi M, Kobayashi Y, Yamamoto Y, Saka S, Yatsu K, Fujikawa T, Toya Y, Yasuda G, Tamura K, Umemura S. Katsumata M, et al. Clin Exp Nephrol. 2017 Oct;21(5):858-865. doi: 10.1007/s10157-016-1379-0. Epub 2017 Feb 11. Clin Exp Nephrol. 2017. PMID: 28190113 Free PMC article.

10

The Efficacy of Tolvaptan in Congestive Heart Failure Patients with and Without Hypoalbuminemia: A Pilot Study.

Okabe T, Yakushiji T, Igawa W, Ono M, Kido T, Ebara S, Yamashita K, Yamamoto MH, Saito S, Hoshimoto K, Amemiya K, Isomura N, Araki H, Ochiai M. Okabe T, et al. Cardiovasc Ther. 2015 Oct;33(5):275-81. doi: 10.1111/1755-5922.12142. Cardiovasc Ther. 2015. PMID: 26122275 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

233 results

Results by year